Institute Research Member, John Stagg, and his team’s work on pancreatic cancer has led to a clinical study by Trishula Therapeutics. Each scientific discovery represents a step closer to a potential treatment to beat cancer.
To learn more about the clinical study, read the press release here.
John Stagg: Identification of CD73 enzyme leads to AstraZeneca drug Oleclumab
15 October 2021
Last September, at the European Society for Medical Oncology Congress, AstraZeneca Pharmaceuticals shared the preliminary results of its recent Phase […]
3 October 2023
As part of its partnership with Uniprix, the Institute is proud to announce that from October 5 to 25, you […]